Saturday 17 October 2026
Export PMI’s income statement to Excel — free account
Flag Ship Acquisition Corp
PMI Healthcare Medical Devices
Flag Ship Acquisition Corp’s revenue for fiscal 2025 (year ended December 2025) was $4.9 million, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 38.6%, EPS grew 92.8%, free cash flow grew 46.8% and total debt fell 89.8%, each against the same quarter a year earlier.
12.75
2.75
+27.50%
Follow PMI
| Dec '25 | Dec '24 | |
|---|---|---|
P/E ratio |
0.00 | 0.00 |
Altman Z-Score |
(4.36) | — |
P/S ratio |
12.84 | 9.41 |
Altman Z″-Score (non-manufacturers) |
(14.26) | (35.56) |
P/FCF ratio |
0.00 | 0.00 |
P/Operating CF |
(14.49) | (16.02) |
P/B ratio |
16.74 | 0.00 |
Price to Tangible BV |
23.79 | 0.00 |
EV/Sales |
10.73 | 10.90 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
(3.38) | (4.47) |
EV/FCF |
(3.38) | (4.47) |
Quick Ratio |
0.65 | 0.02 |
Current Ratio |
1.11 | 0.28 |
Net Debt/EBITDA |
1.27 | (0.48) |
Debt/Assets |
4.57% | 43.32% |
Debt/Equity |
0.27 | (0.22) |
Asset Turnover |
0.29 | 0.00 |
Operating CF/Net income |
0.58 | 0.50 |
Capex/Depreciation |
0.00 | 0.00 |
Interest Coverage |
(2.46) | (4.47) |
| 134.30% | 0.00% | |
| (155.84%) | 0.00% | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
(1,219.60%) | 93.80% |
Average Days of Receivables |
55.93 | 51.95 |
Research and Development Expense of Revenue |
61.72% | 76.98% |
Selling, General and Administrative Expense of Revenue |
202.51% | 232.75% |
Intangible Assets out of Total Assets |
0.05 | 0.10 |
Share Based Compensation of Revenue |
15.26% | 20.18% |
Graham Net Nets |
0.03 | (0.89) |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
(53.56%) | (64.10%) |
Free Cash Flow Yield |
(24.72%) | (25.89%) |
Revenue per Share |
6.82 | 27.63 |
Operating CF per Share |
(21.63) | (74.73) |
Capex per Share |
0.00 | 0.00 |
Free Cash Flow per Share |
(21.63) | (74.73) |
Cash per Share |
15.80 | 0.60 |
Shareholders Equity per Share |
5.23 | (149.38) |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
5.23 | (149.38) |
Free Cash Flow |
(15.67) | (11.87) |
Working Capital |
2.03 | (25.53) |
Net Current Asset Value |
1.97 | (26.05) |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
27.52 | 12.92 |
Cash ROIC |
(96.33%) | 64.55% |
Accounts Receivable Turnover |
7.15 | 0.00 |
Accounts Payable Turnover |
1.40 | 0.00 |
Inventory Turnover |
0.67 | 0.00 |
Average Days of Payables |
147.52 | 429.04 |
Days of Inventory on Hand |
518.20 | 657.78 |
Average Receivables |
0.69 | — |
Average Payables |
3.69 | — |
Average Inventory |
7.71 | — |
Average Assets |
17.33 | — |
Average Common Equity |
(20.11) | — |
Columns are period end dates